Centessa Pharmaceuticals (CNTA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

16.130
-0.530-3.18%

Trading Oct 15 12:23 ET

2.07BMarket Cap-10406P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Centessa Pharmaceuticals Plc (CNTA): A Small-Cap Leader in Clinical-Stage Biotech
Yahoo FinanceOct 12 10:18 ET
Centessa Pharmaceuticals Insider Lowered Holding By 19% During Last Year
Simply Wall StOct 8 09:07 ET
Leerink Partners Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating
Moomoo NewsSep 27 13:32 ET · Ratings
Centessa Pharmaceuticals' ORX142 Shows Promising Preclinical Results and Market Potential
TipRanksSep 27 13:16 ET
BMO Capital Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Maintains Target Price $35
Moomoo NewsSep 27 07:31 ET · Ratings
Oppenheimer Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Maintains Target Price $24
Moomoo NewsSep 26 22:32 ET · Ratings

Comments

Stock_Drift

Sep 26 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy